Turtle Creek Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Turtle Creek Wealth Advisors's VRTX Position: Q1 2026 in Review
Turtle Creek Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 30% in Q1 2026, buying an estimated $100K and bringing the position to 938 shares worth $419K. The position accounts for 0.03% of the portfolio, ranked #262.
Turtle Creek Wealth Advisors first reported a position in VRTX in Q4 2023 and has held it in 5 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Turtle Creek Wealth Advisors held 938 shares of Vertex Pharmaceuticals worth $419K as of Q1 2026.
- Turtle Creek Wealth Advisors bought 215 Vertex Pharmaceuticals shares in Q1 2026, an estimated $100K.
- Vertex Pharmaceuticals made up 0.03% of Turtle Creek Wealth Advisors's portfolio in Q1 2026, its #262 holding.
- Turtle Creek Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Turtle Creek Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.